WeVote
Log In

Bill

Bill

SB 883

Abortion; prohibiting certain acts involving abortion-inducing drugs; providing administrative and criminal penalties. Emergency.

2025 Regular Session Introduced by David Bullard and 1 co-sponsor

Oklahoma bill establishes criminal and administrative penalties for acts involving abortion-inducing drugs, restricting medication abortion access in a state with existing abortion limitations.

Coauthored by Representative CrosswhiteHader (principal House author)
0
WeVote Research Nonpartisan
Bill Summary · SB 883

Legislative bill overview

SB 883 proposes to restrict access to abortion-inducing medications in Oklahoma through administrative and criminal penalties. The bill targets certain acts involving these drugs, though specific provisions are not detailed in the available legislative information. The emergency designation suggests the sponsors view this as time-sensitive legislation.

Why is this important

This bill directly impacts reproductive healthcare access in Oklahoma, a state that already has significant abortion restrictions. The measures could affect medication abortion (pills), which currently accounts for over half of U.S. abortions, and potentially influence telehealth and mail-delivery pharmaceutical services. The criminal and administrative penalties create enforcement mechanisms with real consequences for healthcare providers and potentially patients.

Potential points of contention

  • Constitutional challenges: Medication abortion restrictions face ongoing federal litigation; courts have blocked similar bans in other states, raising questions about enforceability
  • Healthcare provider impacts: Criminal penalties may deter physicians from prescribing these medications even in legally permissible circumstances, affecting medical practice and potentially patient safety
  • Scope and definitions: The bill's language around "certain acts" is vague in available summaries; clarity on what specifically is prohibited (prescribing, dispensing, purchasing, possessing) would significantly affect implementation
  • Interstate commerce issues: Restrictions on mail-delivery medications raise questions about federal authority and enforcement across state lines

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.